Sentinel Lymph Node Mapping with Double Tracer and Double Injection Sites in Early-Stage Endometrium Cancer
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The aim of this prospective study is to investigate whether the detection rate of sentinel lymph node (SLN) with double tracer injected at two different sites may be increased compared to the standard use of a single tracer with single site (cervix) injection in early-stage endometrial cancer.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 90
Healthy Volunteers: f
View:
• Must have preoperative histologic diagnosis of endometrial carcinoma
• Must be in early stage ( stage1 and 2) endometrial carcinoma radiologically and clinically
• Must have written informed consent
Locations
Other Locations
Turkey
Istanbul University Medical Faculty Dept. of Obstet Gynecol, Division of Gynecologic Oncology
RECRUITING
Istanbul
Contact Information
Primary
Mustafa ALBAYRAK, MD
mustafaalbayrak@icloud.com
+905326871051
Backup
Yagmur MİNARECİ, MD
yagmurminareci@gmail.com
+905053574361
Time Frame
Start Date: 2023-07-01
Estimated Completion Date: 2026-05
Participants
Target number of participants: 100
Treatments
Experimental: Sentinel Lymph Node Mapping With Double Tracer in Endometrium Cancer (Single Arm)
Sentinel Lymph Node Mapping With Double Tracer and Double Injection Sites in Early-Stage Endometrium Cancer (Single Arm)
Related Therapeutic Areas
Sponsors
Leads: Istanbul University